內地居民可前往港澳自費接種 mRNA 新冠疫苗復必泰

智通財經
2022.12.19 10:55
復星醫藥宣佈，mRNA 新冠疫苗復必泰 BNT162b2、復必泰二價疫苗均獲正式註冊為中國香港藥品/製品，分別可用於 12 歲及以上人羣的基礎免疫接種、加強接種。這意味着，有接種意願的內地居民可前往中國香港的醫療機構或診所接種該等疫苗。此前，澳門特區也已向內地居民開放自費接種復必泰疫苗。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.